Robitussin Lingering Cold Long-acting Coughgels
NDC Package 0031-8741-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Robitussin Lingering Cold Long-acting Coughgels is a . Marketed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc, this product is identified by NDC 0031-8741 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
0031-8741-20
Package Description
1 BOTTLE in 1 BLISTER PACK / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE
Product Code
0031-8741
11-Digit Billing Format
00031874120
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Robitussin Lingering Cold Long-acting Coughgels
Dosage Form
-

Regulatory & Marketing

Labeler Name
Glaxosmithkline Consumer Healthcare Holdings (us) Llc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
06-06-2011
End Marketing Date
06-01-2022
Listing Expiration
06-01-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0031-8741-20 identifies a specific commercial package of 1 bottle in 1 blister pack / 20 capsule, liquid filled in 1 bottle of Robitussin Lingering Cold Long-acting Coughgels, labeled by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Consumer Healthcare Holdings (us) Llc on June 06, 2011. The current certification is valid through June 01, 2022.

How is this Glaxosmithkline Consumer Healthcare Holdings (us) Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00031874120. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0031-8741-20
11-Digit CMS (5-4-2)
00031-8741-20

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.